Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
1.02M
-
Shares change
-
+580K
-
Total reported value, excl. options
-
$21.1M
-
Value change
-
+$12M
-
Number of buys
-
11
-
Number of sells
-
-4
-
Price
-
$20.66
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q3 2025
19 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q3 2025.
Summit Therapeutics Inc. - COM (SMMT) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.02M shares
.
Largest 10 shareholders include Capricorn Fund Managers Ltd (496K shares), Voya Investment Management LLC (203K shares), GRIFFIN ASSET MANAGEMENT, INC. (140K shares), Polianta Ltd (74.7K shares), Farther Finance Advisors, LLC (55.2K shares), Calamos Advisors LLC (18.6K shares), Three Seasons Wealth, LLC (12.9K shares), U.S. Capital Wealth Advisors, LLC (12K shares), Avanza Fonder AB (4.49K shares), and ADIRONDACK TRUST CO (2.5K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.